Orthopedics faces an unprecedented moment as companies juggle commercializing products alongside their COVID-19 response. We’ve assembled executives from companies of all sizes and across orthopedic market segments to discuss critical topics, including:
• COVID: What is the expected recovery timeline? How has the industry changed?
• Technology: What role will digital and enabling technology play?
• ASCs: Which procedures will shift away from the hospital setting and when?
• M&A: What’s driving today’s acquisition and divestiture environment?
--- Larry Biegelsen, Managing Director, Medical Supplies & Devices, Wells Fargo Securities
--- Jacob Paul, SVP and President of Cranial and Spinal Technologies, Medtronic
--- Benny Hagag, President, MicroPort Orthopedics
--- Albert DaCosta, Founder and CEO, Paragon 28